STEM Review Turks & Caicos: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Review Turks & Caicos.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 14, 2025

November 14, 2025

Synaptics to Participate at Upcoming Investor Conference Wednesday, November 19, 2025

GlobeNewswire

November 14, 2025

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

November 14, 2025

Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference

GlobeNewswire

November 14, 2025

Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

GlobeNewswire

November 14, 2025

Paragon Genomics Introduces New CleanPlex® NGS Panel for Pharmacogenomics Profiling at AMP 2025

GlobeNewswire

November 14, 2025

reAlpha to Host Live Video Call on X Spaces to Discuss Third Quarter 2025 Results

GlobeNewswire

November 14, 2025

Datavault AI to Announce Third Quarter 2025 Financial Highlights and Corporate Update on Monday, Nov. 17, 2025

GlobeNewswire

November 14, 2025

Wrap and K-Form Strengthen Made in America Supply Chain for Wrap’s Non-Lethal Response and CUAS Manufacturing

GlobeNewswire

November 14, 2025

CPI Aerostructures Reports Third Quarter and Nine Month 2025 Results

GlobeNewswire

November 14, 2025

Roadzen Reports $13.7 Million Second Quarter Revenue, a 15.2% Improvement Over Prior Year Quarter, and Fifth Consecutive Quarter of Adjusted EBITDA Improvement

GlobeNewswire

November 14, 2025

Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 14, 2025

PCS Edventures! Announces Results for the Second Quarter of Fiscal Year 2026

GlobeNewswire

November 14, 2025

QIDI Max4: Flagship Large-Scale 3D Printer Debuts at Formnext 2025 in Germany

GlobeNewswire

November 14, 2025

Viewbix Refines Proposed Quantum X Labs Acquisition Terms – Reduces Initial Equity to 40%

GlobeNewswire

November 14, 2025

Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for suprachoroidal delivery

GlobeNewswire

November 14, 2025

Mersana Therapeutics Provides Business Update and Announces Third Quarter 2025 Financial Results

GlobeNewswire

November 14, 2025

Phononic Unleashes AI Data Center Performance Via Advanced Cooling With the Phononic ‘Thermal Kit’

GlobeNewswire

November 14, 2025

New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity

GlobeNewswire

November 14, 2025

Communiqué de presse : Teizeild, un médicament Sanofi, a reçu l’approbation du CHMP pour une autorisation de mise sur le marché dans l’UE chez les patients atteints de diabète de type 1 de stade 2

GlobeNewswire

November 14, 2025

Press Release: Sanofi’s Teizeild recommended for EU approval by the CHMP for patients with stage 2 type 1 diabetes

GlobeNewswire